Monday, October 30, 2017

PHARMACOLOGY OF ANTI-GLAUCOMA MEDICATIONS












It is prudent not to use these drugs in any patient who requires respiratory medications, has a heart rate less than 55beats/minute, has or has had heart failure, or has history of present or past use of antidepressant medications or impotence. A positive history of cardiac problems or symptoms is usually present in patients who have greater than first degree heart block. 




























No comments:

Post a Comment

PLURIPOTENT EPIGENETIC REGULATOR OBP-801

  OBP-801 (also known as YM753) is a novel histone deacetylase (HDAC) inhibitor developed by Oncolys BioPharma for potential anticancer t...